ArticleAging2022

CCL19 has potential to be a potential prognostic biomarker and a modulator of tumor immune microenvironment (TIME) of breast cancer: a comprehensive analysis based on TCGA database.

Jinyan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.